Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Diphtheria"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diphtheria"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
2 Not yet recruiting Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Conditions: Tetanus;   Diphtheria;   Whooping Cough
Interventions: Biological: Biological: GC3111 vaccine;   Biological: Biological: Boostrix® vaccine
3 Not yet recruiting A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Conditions: Haemophilus Influenzae Type B Vaccines;   Diphtheria;   Hepatitis B;   Tetanus;   Pertussis
Intervention: Biological: Infanrix® -IPV/Hib
4 Not yet recruiting Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenza Type B
Intervention:
5 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
6 Not yet recruiting Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Diphtheria;   Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix hexa
7 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
8 Recruiting Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type b
Intervention: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)
9 Unknown  Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan 5
10 Recruiting Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids™ Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix™ (GSK444563) in Healthy Infants
Condition: Rotavirus Vaccines
Interventions: Biological: Squarekids®;   Biological: Rotarix™
11 Not yet recruiting A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Condition: Diphtheria
Intervention: Biological: Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)]
12 Recruiting Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Conditions: Diphtheria;   Acellular Pertussis;   Tetanus
Intervention: Other: Pertussis maternal immunization
13 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions: Biological: Boostrix™;   Drug: Saline placebo
14 Not yet recruiting Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program
Condition: Healthy
Intervention: Biological: Tetanus and Diphtheria (Td) Vaccine
15 Not yet recruiting Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
Condition: Heterologous Effects of Vaccines
Interventions: Biological: Seasonal influenza vaccine;   Biological: Diphtheria-tetanus-acellular pertussis vaccine
16 Unknown  Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
17 Recruiting Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
18 Recruiting Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
19 Recruiting Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Malignant Glioma;   Astrocytoma, Grade IV;   GBM
Interventions: Biological: pp65-shLAMP DC with GM-CSF;   Biological: unpulsed PBMC and saline;   Drug: Td;   Drug: Saline;   Drug: pp65-flLAMP DC with GM-CSF
20 Recruiting Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years